Tag: Michael Parenti

Michael Parenti

General

Guest Commentary: What Might a Part B IPI Model Do to Drug Innovation, Patient Care?

Guest Commentary: What Might a Part B IPI Model Do to Drug Innovation, Patient Care?

By Michael Parenti, Senior Engagement Strategist, Saatchi & Saatchi Wellness Feb. 1, 2019 — On Oct. 25, 2018, the Centers for Medicare and Medicaid Services (CMS) issued an advance notice of proposed rulemaking (ANPRM) to test whether phasing down the Medicare payment amount for selected Part B drugs to more closely align with international prices […]

Read more

CHC News

Guest Commentary: Exploring a New Frontier in Healthcare

Guest Commentary: Exploring a New Frontier in Healthcare

June 26, 2018 — By Michael Parenti, Senior Engagement Strategist, Saatchi & Saatchi Wellness Real world evidence and data privacy regulations were among the hot topics at the Coalition for Healthcare Communication 2018 Rising Leaders Conference on Healthcare Policy. A source of much corporate concern, the European Union’s General Data Protection Regulation (GDPR) finally went […]

Read more